James B Lewin

20PUBLICATIONS
60CO-AUTHORS
Medical infection agents (incl. prions)Medical virologyRheumatology and arthritisMedical mycologyMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 18, 2026
Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.

|May 19, 2026
Evaluation of Documented Infections by Provider Specialty in Patients with Multiple Sclerosis Receiving Disease-Modifying Therapies: A Claims Database Analysis.

|Apr 30, 2026
Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes.

|Feb 18, 2026
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Ahmed Z Obeidat, Michelle Betz, Rebecca Straus Farber

|Oct 13, 2025
Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experience.

Brandi L Vollmer, Tammy Hoyt, Timothy W West

|Oct 07, 2025
Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Cortnee Roman, Meghan Garabedian, Virginia R Schobel

Pageof 4

Frequent Collaborators

12 joint publications

Jason P Mendoza

9 joint publications

Sai L Shankar

5 joint publications

Ivan Bozin

3 joint publications

Boyang Bian